Regeneron Pharmaceuticals is a verified industry giant with exceptional real-world utility, verifiable revenue ($14.2B+ in 2024), and significant global impact through life-saving therapies (Dupixent, Eylea). However, the submission itself is of low quality, using a likely username ('SwiftFang') instead of a professional name and containing hyperbolic, inaccurate claims ('most people have used my product', 'audience reach: everyone'). Despite the lazy submission data, the entity's verifiable track record drives the score into the upper tier, though penalized for lack of precision in the response.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline